These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 4131059)

  • 1. Letter: Blood substitutes.
    Clark LC
    Lancet; 1974 Mar; 1(7854):412. PubMed ID: 4131059
    [No Abstract]   [Full Text] [Related]  

  • 2. Retention of perfluorochemicals in circulating blood and organs of animals after intravenous injection of their emulsions.
    Okamoto H; Yamanouchi K; Yokoyama K
    Chem Pharm Bull (Tokyo); 1975 Jul; 23(7):1452-7. PubMed ID: 1182885
    [No Abstract]   [Full Text] [Related]  

  • 3. Excretion of perfluorochemicals after intravenous injection of their emulsion.
    Yokoyama K; Yamanouchi K; Murashima R
    Chem Pharm Bull (Tokyo); 1975 Jun; 23(6):1368-73. PubMed ID: 1182878
    [No Abstract]   [Full Text] [Related]  

  • 4. Light microscopic morphometry and fine structure of the liver: A response to perfluorinated liquid emulsions used as artificial blood.
    Miller ML; Clark LC; Wesseler EP; Stanley L; Emory C; Kaplan S
    Ala J Med Sci; 1975 Jan; 12(1):84-113. PubMed ID: 1155745
    [No Abstract]   [Full Text] [Related]  

  • 5. Determination of perfluorochemicals in organs and body fluids by gas chromatography.
    Yamanouchi K; Murashima R; Yokoyama K
    Chem Pharm Bull (Tokyo); 1975 Jun; 23(6):1363-7. PubMed ID: 1182877
    [No Abstract]   [Full Text] [Related]  

  • 6. Intravascular persistence, tissue storage, and excretion of hydroxyethyl starch.
    Thompson WL; Fukushima T; Rutherford RB; Walton RP
    Surg Gynecol Obstet; 1970 Nov; 131(5):965-72. PubMed ID: 5471548
    [No Abstract]   [Full Text] [Related]  

  • 7. [New types of synthetic infusion solutions. Basic biological properties of poly(N-(2-hydroxypropyl) methacrylamide) (author's transl)].
    Stĕrba O; Paluska E; Jozová O; Spunda J; Nezvalová J; Sprincl L; Kopecek J; Cinátl J
    Cas Lek Cesk; 1975 Oct; 114(41):1268-70. PubMed ID: 1192450
    [No Abstract]   [Full Text] [Related]  

  • 8. In vitro depression of tissue oxygen uptake by liquid fluorocarbon prepared as artificial blood.
    Rosenblum WI; Navari RM; Levasseur JE; Patterson JL
    Proc Soc Exp Biol Med; 1977 Mar; 154(3):346-50. PubMed ID: 846993
    [No Abstract]   [Full Text] [Related]  

  • 9. [Erythrocyte model for evaluation of gas transport capacity of blood substitutes in vitro].
    Kuznetsova IN; Chaplygina ZA
    Probl Gematol Pereliv Krovi; 1974 Apr; 19(4):53-5. PubMed ID: 4832850
    [No Abstract]   [Full Text] [Related]  

  • 10. Fate of fluorinated metabolites of inhalation anesthetics in man.
    Holaday DA; Fiserova-Bergerova V
    Drug Metab Rev; 1979; 9(1):61-78. PubMed ID: 36268
    [No Abstract]   [Full Text] [Related]  

  • 11. The renal clearance of plasma expanders.
    METCALF W; ROUSSELOT LM; GILBERTSON FE
    Surg Forum; 1955; 5():520-3. PubMed ID: 13247082
    [No Abstract]   [Full Text] [Related]  

  • 12. [Several aspects of fluoracizine metabolism].
    Vikhliaev IuI; Zherdev VP
    Farmakol Toksikol; 1973; 36(2):167-72. PubMed ID: 4791596
    [No Abstract]   [Full Text] [Related]  

  • 13. [On excretion of the plasma substitute solution "zhelatinol"].
    Znamenskaia TV
    Probl Gematol Pereliv Krovi; 1966 Jul; 11(7):37-42. PubMed ID: 6002179
    [No Abstract]   [Full Text] [Related]  

  • 14. Determination of particle size distribution of fluorocarbon emulsion by means of centrifugal sedimentation--a proposal for specifying the particle size distribution.
    Yokoyama K; Suzuki A; Utsumi I; Naito R
    Chem Pharm Bull (Tokyo); 1974 Dec; 22(12):2966-71. PubMed ID: 4468117
    [No Abstract]   [Full Text] [Related]  

  • 15. [The duration of circulation in the vascular bed and elimination from the body of the blood substitute geosen].
    Bryzgina TM; Aleksiuk LI
    Fiziol Zh; 1975; 21(2):195-200. PubMed ID: 1126476
    [No Abstract]   [Full Text] [Related]  

  • 16. Transformations of solutes administered during anesthesia.
    dal Santo G
    Int Anesthesiol Clin; 1975; 13(4):147-64. PubMed ID: 1107230
    [No Abstract]   [Full Text] [Related]  

  • 17. [Storing of plasma expanders in the reticuloendothelial system].
    Sonntag W; Paulini K
    Verh Dtsch Ges Pathol; 1978; 62():346. PubMed ID: 85388
    [No Abstract]   [Full Text] [Related]  

  • 18. [The distribution and effects of fluoracizine in rats administered by different routes].
    Vikhliaev IuI; Zherdev VP; Ul'ianova OV
    Farmakol Toksikol; 1973; 36(5):534-8. PubMed ID: 4799150
    [No Abstract]   [Full Text] [Related]  

  • 19. Perfluoro compounds as blood substitutes.
    Riess JG; Le Blanc M
    Angew Chem Int Ed Engl; 1978 Sep; 17(9):621-34. PubMed ID: 101099
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinical pharmacology of plasma expanders].
    Zaffiri O; Mastroianni A; Contratti V; Francescato F
    Minerva Anestesiol; 1969 May; 35(5):589-95. PubMed ID: 5788281
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.